SELSUN

This brand name is authorized in Australia, France, Hong Kong SAR China, Ireland, Netherlands, New Zealand, UK.

Active ingredients

The drug SELSUN contains one active pharmaceutical ingredient (API):

1	Selenium sulfide UNII Z69D9E381Q - SELENIUM SULFIDE
	Selenium sulfide appears to have a cytostatic effect on cells of the epidermis and follicular epithelium, reducing corneocyte production.
	Read more about Selenium sulfide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SELSUN Shampoo	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D01AE13	Selenium sulfide	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AE Other antifungals for topical use
Discover more medicines within D01AE13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	4452H
FR	Base de données publique des médicaments	68747418
GB	Medicines & Healthcare Products Regulatory Agency	24636, 24637, 24638
HK	Department of Health Drug Office	04190, 27702, 37828, 48503, 60691, 61296, 61297, 63991
NL	Z-Index G-Standaard	14915464, 14915472
NL	Z-Index G-Standaard, PRK	337
NZ	Medicines and Medical Devices Safety Authority	1456